We are an independent, global, inter-disciplinary, non-partisan group of policy-makers, scholars, scientists, strategists and others convened to think through the wide range of issues and crises associated with the Covid-19 pandemic. The Commission’s purpose is to enable informed discourse and decision-making, to frame priorities and help build consensus on policy solutions to strengthen societal and global resilience. The full list of Commissioners can be found here.

Earth Globe held by gloved hands with green plant sprouting

Argument: Vaccine licensing

By Michael Spence, Commissioner, GCPPP, May 12th 2021

Of the two approaches under discussion — IP rights suspension, as supported by the Biden administration, or compulsory licensing — mandatory licensing is preferable because it acknowledges that the creator and producer of the drug or vaccine is entitled to a return, and so has less potential effect on future incentives to create and produce.

At this juncture in the pandemic, the big question before the World Trade Organization (WTO), the World Health Organization (WHO), and all global leaders is whether vaccine production and delivery can be ramped up quickly enough to allow a large majority of people around the world to be vaccinated relatively soon – the next year perhaps.  Lying behind that question is whether and under what circumstances it is appropriate to suspend domestic and internationally agreed intellectual property rights.  The matter is being discussed in the WTO right now, and the Biden administration’s surprise expression of support for suspension on May 5th has exposed a rift between western governments over the issue.

What we know about long COVID

By Dylan Barry, GCPPP staff, May 5th 2021

This Research Monitor looks at the still somewhat mysterious post-acute COVID-19 syndrome (PACS), known as long COVID, at its features and potential explanations, at treatments and at the syndrome’s potential long-term health and economic legacies. 

multi-racial Emoji faces with mask

The Pandemic This Week

Our summary of the main pandemic crises-related news in the week to May 10th.

COVAX: A Roadmap

By Dylan Barry, GCPPP Staff

This Policy Monitor looks at what the global COVAX initiative for supplying vaccines chiefly to poor countries can be expected to achieve.

From our research partners

The very best global data service on COVID-19 comes from the Oxford Martin School and the “Our World in Data” service associated with it.